Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Treatment of Macular Edema Secondary to Uveitis Using Topical Interferon Gamma
Authors not listed
National Eye Institute (NEI) · 2011
Abstract
The objective of this study is to investigate the safety and efficacy of ocular instillations of interferon gamma-1b as a potential treatment for cystoid macular edema (CME) secondary to uveitis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Anonymous. (2011). The Treatment of Macular Edema Secondary to Uveitis Using Topical Interferon Gamma. <em>National Eye Institute (NEI)</em>. https://clinicaltrials.gov/study/NCT01376362
Vancouver
Anonymous. The Treatment of Macular Edema Secondary to Uveitis Using Topical Interferon Gamma. National Eye Institute (NEI). 2011.
BibTeX
@misc{anon2011TheTre,
title = {The Treatment of Macular Edema Secondary to Uveitis Using Topical Interferon Gamma},
author = {Anonymous},
journal = {National Eye Institute (NEI)},
year = {2011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Heidelberg University 2006
Open access · US-GOV
A Monocentric, Randomized, Controlled Trial to Test the Efficacy of Interferon-beta in the Treatment of Disseminated Encephalomyelitis (ED)-Associated and Primary Intermediate Uveitis in Comparison to Standard Treatment (TEAM)
Dongyang People's Hospital 2023
Open access · US-GOV
Traditional Chinese Medicine and Ranibizumab in the Treatment of Macular Cystoid Edema Associated With Retinal Vein Obstruction.
Allergan 2004
Open access · US-GOV
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
Sanwa Kagaku Kenkyusho Co., Ltd.
Open access · US-GOV
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
American Journal of Ophthalmology 2007
Citation only
Ranibizumab According to Need: A Treatment for Age-related Macular Degeneration
Bayer 2021
Open access · US-GOV